These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 24195589

  • 1. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
    Aminzadeh MA, Reisman SA, Vaziri ND, Khazaeli M, Yuan J, Meyer CJ.
    Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589
    [Abstract] [Full Text] [Related]

  • 2. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
    Aminzadeh MA, Reisman SA, Vaziri ND, Shelkovnikov S, Farzaneh SH, Khazaeli M, Meyer CJ.
    Redox Biol; 2013 Jun; 1(1):527-31. PubMed ID: 24363993
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
    Vaziri ND, Liu S, Farzaneh SH, Nazertehrani S, Khazaeli M, Zhao YY.
    Free Radic Biol Med; 2015 Sep; 86():374-81. PubMed ID: 25930007
    [Abstract] [Full Text] [Related]

  • 4. Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Ameliorates Acute Pancreatitis.
    Robles L, Vaziri ND, Li S, Masuda Y, Takasu C, Takasu M, Vo K, Farzaneh SH, Stamos MJ, Ichii H.
    Pancreas; 2016 Sep; 45(5):720-9. PubMed ID: 26495793
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
    Kim HJ, Vaziri ND.
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
    [Abstract] [Full Text] [Related]

  • 8. Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.
    Lau WL, Liu SM, Pahlevan S, Yuan J, Khazaeli M, Ni Z, Chan JY, Vaziri ND.
    Dig Dis Sci; 2015 May; 60(5):1215-22. PubMed ID: 25399330
    [Abstract] [Full Text] [Related]

  • 9. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
    An WS, Kim HJ, Cho KH, Vaziri ND.
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F895-903. PubMed ID: 19656915
    [Abstract] [Full Text] [Related]

  • 10. Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2.
    Xing Y, Niu T, Wang W, Li J, Li S, Janicki JS, Ruiz S, Meyer CJ, Wang XL, Tang D, Zhao Y, Cui T.
    PLoS One; 2012 Oct; 7(9):e44899. PubMed ID: 23028668
    [Abstract] [Full Text] [Related]

  • 11. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy.
    Aminzadeh MA, Nicholas SB, Norris KC, Vaziri ND.
    Nephrol Dial Transplant; 2013 Aug; 28(8):2038-45. PubMed ID: 23512109
    [Abstract] [Full Text] [Related]

  • 12. Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.
    Ichikawa T, Li J, Meyer CJ, Janicki JS, Hannink M, Cui T.
    PLoS One; 2009 Dec 21; 4(12):e8391. PubMed ID: 20027226
    [Abstract] [Full Text] [Related]

  • 13. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
    Song MK, Lee JH, Ryoo IG, Lee SH, Ku SK, Kwak MK.
    Free Radic Biol Med; 2019 Jul 21; 138():33-42. PubMed ID: 31059771
    [Abstract] [Full Text] [Related]

  • 14. The effect of Nrf2 pathway activation on human pancreatic islet cells.
    Masuda Y, Vaziri ND, Li S, Le A, Hajighasemi-Ossareh M, Robles L, Foster CE, Stamos MJ, Al-Abodullah I, Ricordi C, Ichii H.
    PLoS One; 2015 Jul 21; 10(6):e0131012. PubMed ID: 26110640
    [Abstract] [Full Text] [Related]

  • 15. The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling.
    Bubb KJ, Kok C, Tang O, Rasko NB, Birgisdottir AB, Hansen T, Ritchie R, Bhindi R, Reisman SA, Meyer C, Ward K, Karimi Galougahi K, Figtree GA.
    Free Radic Biol Med; 2017 Jul 21; 108():585-594. PubMed ID: 28438659
    [Abstract] [Full Text] [Related]

  • 16. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.
    Ruiz S, Pergola PE, Zager RA, Vaziri ND.
    Kidney Int; 2013 Jun 21; 83(6):1029-41. PubMed ID: 23325084
    [Abstract] [Full Text] [Related]

  • 17. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M, Suzuki N, Yamamoto M.
    Am J Nephrol; 2017 Jun 21; 45(6):473-483. PubMed ID: 28502971
    [Abstract] [Full Text] [Related]

  • 18. Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2.
    Li B, Abdalrahman A, Lai Y, Janicki JS, Ward KW, Meyer CJ, Wang XL, Tang D, Cui T.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):555-61. PubMed ID: 24486487
    [Abstract] [Full Text] [Related]

  • 19. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
    Wang DT, Huang RH, Cheng X, Zhang ZH, Yang YJ, Lin X.
    Int Immunopharmacol; 2015 May 21; 26(1):4-12. PubMed ID: 25744602
    [Abstract] [Full Text] [Related]

  • 20. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
    Siracusa R, D'Amico R, Cordaro M, Peritore AF, Genovese T, Gugliandolo E, Crupi R, Impellizzeri D, Cuzzocrea S, Fusco R, Di Paola R.
    Int J Mol Sci; 2021 Apr 13; 22(8):. PubMed ID: 33924360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.